← Open Payments lookup

TINA GRIFFIN: Open Payments

NPI 1154945541 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,840 in 98 payments from 20 companies in 2025. Trend: 2023 $1,661 · 2024 $1,904 · 2025 $1,840

Food & beverage: $1,840
CompanyPaymentsAmount
Lilly USA, LLC17$297
Kowa Pharmaceuticals America, Inc.13$265
AstraZeneca Pharmaceuticals LP14$227
GlaxoSmithKline, LLC.8$153
Novo Nordisk Inc11$149
Amgen Inc.1$122
Sumitomo Pharma America, Inc.6$110
PFIZER INC.4$72
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$61
Boehringer Ingelheim Pharmaceuticals, Inc.3$58

Products named: ZORYVE, MOUNJARO, BREZTRI, SHINGRIX, OTEZLA, Ozempic, JARDIANCE, GEMTESA.

Industry payments across LA — which companies pay providers there.